Viral Nucleic Acid Testing (NAT) and OPO-Level Disposition of High-Risk Donor Organs
Open Access
- 1 March 2009
- journal article
- Published by Elsevier in American Journal of Transplantation
- Vol. 9 (3) , 620-628
- https://doi.org/10.1111/j.1600-6143.2008.02522.x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- The Risk of HIV, HBV, HCV and HTLV Infection Among Musculoskeletal Tissue Donors in AustraliaAmerican Journal of Transplantation, 2007
- Assessing the impact of HBV NAT on window period reduction and residual riskJournal of Clinical Virology, 2006
- The Effect of HBsAg-Positivity of Kidney Donors on Long-Term Patient and Graft OutcomeTransplantation Proceedings, 2005
- A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donorsTransfusion, 2005
- The Impact of Transplantation with Deceased Donor Hepatitis C-Positive Kidneys on Survival in Wait-Listed Long-term Dialysis PatientsAmerican Journal of Transplantation, 2004
- Dynamics of HIV viremia and antibody seroconversion in plasma donorsAIDS, 2003
- Elimination of false-negative hepatitis C virus RNA results by removal of inhibitors in cadaver-organ donor blood specimensTransplantation, 2003
- Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infectionTransfusion, 2003
- Significant Closure of the Human Immunodeficiency Virus Type 1 and Hepatitis C Virus Preseroconversion Detection Windows with a Transcription-Mediated-Amplification-Driven AssayJournal of Clinical Microbiology, 2002
- Human Immunodeficiency Virus Infection in Patients with Solid-Organ Transplants: Report of Five Cases and ReviewClinical Infectious Diseases, 1991